[1]
“Stability-Indicating Method Development and Validation for Simultaneous Estimation of Ombitasvir, Paritaprevir, and Ritonavir in Formulation by Ultra Performance Liquid Chromatography”, Int. J. Pharm. Sci. Drug Res., vol. 12, no. 5, pp. 457–463, Sep. 2020, doi: 10.25004/IJPSDR.2020.120505.